ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

GAO Backs DeVita On Why advances Aren’t Producing Mortality Reduction

February 5, 1988

NYC Doctor Pays $2.35 Million To Settle False Claims Act Suit Over Radiosurgery Reimbursements

December 5, 2014

FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.

March 4, 2005

Report Doesn’t Quell Concerns About Duke Genomics Research, Biostatisticians Say

May 14, 2010

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

April 7, 1995

Risks Of Long-Term HRT Outweigh Benefits, WHI Finds

March 28, 2008